Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
4d
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NYC congestion pricing plan
Debris falls from roof
Updates nuclear doctrine
Rookie of the Year winners
Transportation secretary pick
Travel guide innovator dies
Bulls legend dies at 81
GA court cancels hearing
FAU fires coach
To cut workforce
Enters race for DNC chair
22 trapped for 2 hours
Condemns neo-Nazi march
Driver's bias verdict reduced
Labor agency dispute
Russia vetoes UN resolution
To perform at NFL halftime
Border wall trial delayed
US opens two new probes
‘One Tree Hill' actor dies
Settler group sanctioned
NYC issues drought warning
Seeks Capitol bathroom ban
2nd-oldest US resident dies
Election officials rebuked
Riley murder trial resumes
Former soldier sentenced
Huckabee's Meta suit tossed
Windsor burglary probe
WY abortion laws rejected
NBA YoungBoy pleads guilty
Feedback